Restricting routine CD@ monitoring to after @ weeks following ART initiation and removing toxicity testing was associated with an incremental cost-effectiveness ratio of $ @ per quality-adjusted life-year ( QALY ) across all age groups , but was much lower for older children ( @ + years at initiation ; incremental cost-effectiveness ratio = $ @/QALY ) .